CDMO Capabilities

Buprenorphine Oral Lyophilisate is a rapidly dispersing formulation designed for the treatment of opioid dependence as part of a comprehensive care program including medical, social, and psychological support. The product contains buprenorphine, a partial opioid agonist that helps reduce withdrawal symptom...

Substitution treatment for opioid drug dependence,within a framework of medical, social andpsychological treatment

Treatment of apnoea of prematurity

Calcium folinate rescue to reduce methotrexate/folic acid antagonist toxicity and manage overdose.In combination with 5-fluorouracil in cytotoxictherapy

Hypertension, Heart Failure, Myocardial Infarction,Type I Diabetic Nephropathy.Can be used alone and in combination with otherantihypertensive agents, especially thiazide diuretics

Used during heart surgery to induce cardioplegia

Treatment of the infections, caused by microorganismssensitive to ciprofloxacin

Treatment of the infections, caused by microorganisms sensitive to clarithromycin

Clobazam Oral Suspension is a benzodiazepine indicated as adjunctive therapy in epilepsy when standard treatments are insufficient. It offers flexible dosing and is suitable for patients who require a liquid formulation, including paediatric populations. Available in two strengths and multiple bottle sizes...

Treatment of serious infections due to selectedaerobic Gram-negative pathogens

Light sedation before procedures and at ICU

Reversal of hypotension from spinal or epidural anaesthesia

This is a brochure consist of the product portfolio of Ethypharm.